The Democratic Republic of Congo’s latest Ebola outbreak has exceeded 2,000 confirmed infections, with health officials reporting hundreds of deaths as international agencies warn the epidemic may be far more widespread than official figures indicate.
According to the latest data released by Congolese health authorities, the country has recorded more than 2,000 Ebola cases, including 754 fatalities. The outbreak has now spread across five provinces, raising concerns among public health experts about its accelerating pace.
The World Health Organization (WHO) believes the actual number of infections could be significantly higher than confirmed statistics suggest. Officials estimate the outbreak may be between two and four times larger than current reported figures because many cases remain undetected.
Health authorities are particularly concerned about the Bundibugyo strain of the Ebola virus responsible for the current outbreak. Unlike the more common Zaire strain, there is currently no approved vaccine or licensed treatment specifically designed to combat this variant.
In an effort to identify an effective therapy, researchers have launched the first clinical trial targeting the Bundibugyo strain. The study, known as EBO-PEP, began this week and is evaluating the antiviral drug obeldesivir in people who have been exposed to confirmed Ebola patients.
The experimental medication was developed by U.S.-based pharmaceutical company Gilead Sciences and has previously demonstrated encouraging results in laboratory and pre-clinical studies against filoviruses, the group of viruses responsible for Ebola and other viral hemorrhagic fevers.
Medical charity Doctors Without Borders (Médecins Sans Frontières, MSF) has warned that the epidemic is expanding at an unprecedented rate and reaching new regions of the country.
The organization reported that the number of confirmed infections has tripled in less than five weeks, while deaths have increased more than fivefold during the same period. MSF also noted that the current outbreak has already surpassed half the total number of infections recorded during the country’s major Ebola epidemic between 2018 and 2020, which lasted nearly two years.
WHO emergencies chief Dr. Chikwe Ihekweazu has expressed concern over the growing difficulty in tracing the virus. He revealed that around 80 percent of newly identified patients were not previously listed as contacts of confirmed cases, indicating widespread community transmission through unknown chains of infection.
Another major challenge is that many infected individuals are dying before reaching medical facilities, making surveillance, diagnosis, and containment considerably more difficult.
The current outbreak was officially declared on May 15 after several Ebola cases were detected in Ituri Province in northeastern Democratic Republic of Congo. The mineral-rich region has long been affected by armed conflict and recurring violence, creating significant obstacles for healthcare workers attempting to identify cases, trace contacts, and deliver treatment.
Health authorities, humanitarian organizations, and international partners continue to expand surveillance, patient care, laboratory testing, and community awareness campaigns in an effort to contain the outbreak before it spreads further across the country.
Discover more from Niyi Daram
Subscribe to get the latest posts sent to your email.
